Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Lasa Supergenerics Ltd. ( (IN:LASA) ) has issued an announcement.
Lasa Supergenerics Ltd. held a board meeting on September 5, 2025, where several key decisions were made. The board approved the notice for the company’s 10th Annual General Meeting, scheduled for September 30, 2025, to be conducted via video conferencing. Additionally, the board approved the Director’s Report and related documents for the financial year ending March 31, 2025, appointed Shravan A. Gupta & Associates as the scrutinizer for the AGM, and re-appointed Mr. Omkar Herlekar as a director. The company also announced the closure of its Register of Members and Share Transfer Books from September 23 to September 29, 2025.
More about Lasa Supergenerics Ltd.
Lasa Supergenerics Ltd. operates in the pharmaceutical industry, focusing on the production of active pharmaceutical ingredients (APIs) and intermediates. The company is based in the Lote Parshuram Industrial Area, Ratnagiri, and is listed on both the BSE and NSE stock exchanges.
Average Trading Volume: 26,775
Technical Sentiment Signal: Sell
Current Market Cap: 436.4M INR
For detailed information about LASA stock, go to TipRanks’ Stock Analysis page.